Dental 3D Printing company Graphy signs first KRW 2 billion supply agreement with MegaGen

DentalGoodNews｜On October 7, 2026, local time (Korea Standard Time), Graphy Inc. (KOSDAQ: 318060, hereinafter "Graphy"), a Korean dental 3D Printing Material company, signed its first supply agreement with implant company MegaGen Implant Co., Ltd. (hereinafter "MegaGen") at its Seoul headquarters, worth approximately KRW 2 billion (approximately RMB 10 million). The agreement covers Tera Harz E-Namel resin, 3D printers, nitrogen curing equipment, and resin removal equipment.

According to previous DGN reports, Graphy signed a share transfer agreement with digital diagnostic equipment company Ray Co., Ltd. (hereinafter "Ray") on August 10, 2026, acquiring a 26.14% stake in Ray for approximately KRW 49.2 billion; the shares involved in the transaction were transferred in two stages on September 15 and 16. Graphy stated that the transfer was completed in September, through which Graphy became the largest shareholder of Ray, while MegaGen is the second largest shareholder of Ray.

This supply agreement represents the concretization of product and channel cooperation between the two parties following Graphy's acquisition of Ray's equity. The two parties are also in the final stage of negotiations for an annual supply agreement for Ray's Cone Beam Computed Tomography (CBCT) equipment. If reached, it will connect Ray's imaging diagnostic equipment, MegaGen's implant business, and Graphy's 3D Printing Materials and equipment.

Shim Woon-sup (심운섭), Chairman of Graphy Group, stated that this KRW 2 billion supply agreement is the starting point of cooperation between the two parties, and the company plans to expand clinical applications and customer adoption to achieve continuous supply. MegaGen stated that it will integrate Graphy's 3D Printing restoration technology into its digital treatment workflow and develop it into an integrated solution.